Commentary · 8 Jun 2026
Conference abstractPublished 21 Nov 2013
Treating excitatory/inhibitory imbalance to improve learning and memory in Down syndrome and Alzheimer�s disease
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Cognitive impairment is a dominant component of Down Syndrome (DS) and Alzheimer�s Disease (AD). In addition, individuals with Down Syndrome have an extra copy of the APP gene and are at high risk for early onset of Alzheimer�s Disease. A proper excitatory/inhibitory (E/I) balance is necessary for neuronal survival and for induction of the synaptic plasticity that underlies learning and memory. A disrupted E/I balance may play an important role in the learning disabilities of DS and AD. On the one hand, excessive excitatory activity at glutamatergic synapses may induce epileptic activity and excitotoxic neuronal injury. On the other hand, increased neuronal inhibition, possibly elicited as an adaptive response to over-excitation, may impact synaptic plasticity necessary for learning and memory. To test the hypothesis that the cognitive disability in DS, in AD, and in DS with AD is largely due to excessive inhibition, we have explored the therapeutic effects of antagonists of the major CNS inhibitory neurotransmitter gamma-aminobutyric acid (GABA), and specifically antagonists of the GABAA receptor. Acute, subconvulsive doses of the non-competitive GABAA antagonist pentylenetetrazole (PTZ) given prior to a learning experience improved memory in DS model mice, but more significantly, a two week chronic regimen of daily PTZ doses 10 to 100 fold below the seizure threshold resulted in a long lasting (>2 mo) normalization of learning and memory in these DS model mice. These effects were seen in young, adult, and aged DS mice. PTZ efficacy was shown to be dependent on time of day of dosing and the occurrence of sleep.
Subjects
Neuroscience & NeurologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Alzheimers Disease & Parkinsonism.
Perspective · 8 Jun 2026
Oxidative Stress and Its Role in Neuronal Degeneration: Mechanisms and Implications
Commentary · 8 Jun 2026
Understanding the Pathophysiology of Prion-Induced Dementia
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Alzheimers Disease & Parkinsonism
- SubjectNeuroscience & Neurology
- BylineArticles whose byline prints “H. Craig Heller”